Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 18;14(4):e24248.
doi: 10.7759/cureus.24248. eCollection 2022 Apr.

Prevalence of Hypertension in Sudanese Patients With Gouty Arthritis

Affiliations

Prevalence of Hypertension in Sudanese Patients With Gouty Arthritis

Sufian M Khaild et al. Cureus. .

Abstract

Background In this study, we aimed to study the frequency of hypertension in Sudanese patients with gouty arthritis attending the largest three tertiary hospitals in Khartoum and correlate it with serum uric acid levels. Methodology An observational, descriptive, cross-sectional, hospital-based study was conducted in rheumatology clinics in Khartoum state, Sudan, from August 2020 to January 2021 involving 100 participants. Data were collected, prepared, and analyzed using SPSS version 25.0 (IBM Corp., Armonk, NY, USA). Results In this study, 100 participants were enrolled. The majority were males (79%), with 45% of the participants in the age group of 61-75 years. Overall, 89% of participants had symptoms of gouty arthritis, with the knee being the most common joint affected in 27% of participants. Most participants had a uric acid level above the target (6 mg/dL). The most frequently used uric acid lowering agent was found to be allopurinol in 85% of the patients. Furthermore, among those with gouty arthritis, 51% had hypertension with nearly half being insufficiently controlled. The frequency of undiagnosed hypertension among the participants was found to be 19%, which was statistically significant among gouty arthritis patients (p-value < 0.0001). Upon further analysis of our hypertensive participants, 79.5% of males (n = 35) had high blood pressure levels, which was statistically significant as well (p-value = 0.005), with the highest prevalence being among the age group of 61-75 years. Of those who were hypertensive, 51% had a history of concomitant comorbidity. Overall, 90% of the hypertensive participants (n = 40) had joint symptoms. Moreover, serum uric acid level was above the target in 93% of the participants. Conclusions Hypertension was found to be the most frequently recognized comorbidity in gouty arthritic patients, with more than a third remaining undiagnosed. Moreover, the male gender was a significant risk factor for hypertension among the gouty arthritis participants. Nevertheless, most patients with high blood pressure levels had concurrent elevated uric acid levels.

Keywords: allopurinol; arthralgia; gouty arthritis; hypertension; uric acid.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Hypertension characteristics in the gouty arthritis study group.

Similar articles

Cited by

References

    1. Comorbidities in gout and hyperuricemia: causality or epiphenomena? Sumpter NA, Saag KG, Reynolds RJ, Merriman TR. Curr Opin Rheumatol. 2020;32:126–133. - PubMed
    1. Gaffo AL. UpToDate. Philadelphia, PA: Wolters Kluwer; 2022. Clinical manifestations and diagnosis of gout.
    1. Longitudinal transition trajectory of gouty arthritis and its comorbidities: a population-based study. Huang CF, Liu JC, Huang HC, Chuang SY, Chen CI, Lin KC. Rheumatol Int. 2017;37:313–322. - PubMed
    1. Prevalence of comorbidities and management of gout in a tropical city in Australia. Jeyaruban A, Soden M, Larkins S. Rheumatol Int. 2016;36:1753–1758. - PubMed
    1. The absolute risk of gout by clusters of gout-associated comorbidities and lifestyle factors-30 years follow-up of the Malmö Preventive Project. Fatima T, Nilsson PM, Turesson C, Dehlin M, Dalbeth N, Jacobsson LT, Kapetanovic MC. Arthritis Res Ther. 2020;22:244. - PMC - PubMed

LinkOut - more resources